Cambre Jerome 4

4 · VIEMED HEALTHCARE, INC. · Filed Feb 2, 2026

AI-generated summary of this filing

Updated Feb 2, 2026

Viemed (VMD) VP of Sales Jerome Cambre Receives Awards; Shares Withheld

What Happened

Jerome Cambre, Vice President of Sales at Viemed Healthcare (VMD), had restricted stock units (RSUs) and phantom share units vest on January 29, 2026. A total of 11,492 shares were reported as acquired via exercise/conversion of derivatives/awards (8,619 + 2,873).
From the vesting event: 2,355 shares were withheld by the issuer to cover tax withholding (reported value $7.48/share, $17,615 total) and 2,873 shares were disposed to the issuer/cashed out at $7.48/share for $21,490. Some derivative items were reported with $0 derivative value reflecting cash-settlement mechanics for phantom shares.
Net of the withholding and cash settlement, Cambre retained 6,264 shares from this vesting. These were award/vesting transactions (not an open-market purchase) — routine compensation-related activity rather than a market timing trade.

Key Details

Transaction date: January 29, 2026; Form 4 filed February 2, 2026 (appears timely).
Reported per-share valuation: $7.48 (based on market close on Jan 29, 2026).
Reported activity: 11,492 shares acquired via vesting/conversion; 2,355 shares withheld for taxes ($17,615); 2,873 shares cashed/disposed to issuer ($21,490). Some derivative dispositions reported at $0 reflecting cash settlement of phantom shares.
Footnotes: RSUs = one-for-one common shares (F1, F5). Phantom shares are cash-settled equivalents to common shares (F4, F6). Withholding to satisfy tax obligations is standard (F2). Per-share value note (F3).
Shares owned after transaction: Cambre retained a net 6,264 shares from this vesting (11,492 acquired minus 2,355 withheld minus 2,873 cashed). The Form 4 did not report any separate open-market purchases or sales beyond these compensation-related transactions.

Context

This was primarily a vesting/settlement event (awards and cash-settled phantom shares). The cash settlement and issuer buyback are standard ways companies or plans handle taxes and phantom-unit payouts; they do not necessarily indicate insider bullishness or bearishness.
For clarity: M = exercise/conversion of derivative, F = tax withholding, D = disposition to issuer. These are compensation-related filings rather than discretionary sales or purchases on the open market.

Form 4

Period: 2026-01-29

Vice President of Sales

Transactions

Exercise/Conversion
Common Shares
[F1]
2026-01-29+8,619→ 106,443 total
Tax Payment
Common Shares
[F2][F3]
2026-01-29$7.48/sh−2,355$17,615→ 104,088 total
Exercise/Conversion
Common Shares
[F4]
2026-01-29+2,873→ 106,961 total
Disposition to Issuer
Common Shares
[F3]
2026-01-29$7.48/sh−2,873$21,490→ 104,088 total
Exercise/Conversion
Restricted Stock Units
[F1][F5]
2026-01-29−8,619→ 8,619 total
Exp: 2027-01-29→ Common Shares (8,619 underlying)
Exercise/Conversion
Phantom Share Units
[F4][F6]
2026-01-29−2,873→ 2,873 total
Exp: 2027-01-29→ Common Shares (2,873 underlying)

Footnotes (6)

[F1]Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
[F2]Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
[F3]Per share value is based on the market closing price of the common shares for January 29, 2026.
[F4]Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
[F5]Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date.
[F6]Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.

Signature

/s/ Jesse Bergeron, Attorney-in-Fact|2026-02-02

1 file